| Detected | Trial | Change |
|---|---|---|
| 2026-05-29 | NCT07028853 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat… |
Trial sites expanded: 305 -> 329 locations |
| 2026-05-23 | NCT07028853 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat… |
Trial sites expanded: 302 -> 305 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-18 | NCT07592910 A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06629779 | A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic… | Metastatic Castration-Resistant Prostate Cancer | Recruiting |
| NCT07028853 | This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat… | Metastatic Castration Sensitive Prostate Cancer (mCSPC) | Recruiting |
| NCT06551324 | A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in… | Metastatic Castrate Resistant Prostate Cancer (mCRPC) | Active, Not Recruiting |
| Phase 2 | |||
| NCT07592910 | A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have… | Metastatic Castrate Resistant Prostate Cancer (mCRPC) | Not Yet Recruiting |
| Phase 1 | |||
| NCT03460977 | A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant… | Metastatic Castration Resistant Prostate Cancer (mCRPC) | Recruiting |